The Life Sciences Investment Programme (LSIP) is a £200m initiative managed by British Business Bank designed to address the growth equity finance gap faced by high-potential UK life sciences companies. This is expected to attract at least a further £400m of private investment.
Through LSIP, we make cornerstone commitments to later stage life sciences venture growth funds with a strong UK focus, typically investing between £50m and £100m in each successful fund.
Key features
- Dedicated life sciences focus
- Funds providing later-stage capital
- UK presence in investment team
- Minimum target fund size of £250m
- Focus on funding UK companies
Find out more
For further information please see our Request for Proposals.
If you have any queries please contact [email protected].
Related articles
What is a commercial finance broker?
Read article What is a commercial finance broker?
Navigating competition exclusions in the Procurement Act 2023
Read article Navigating competition exclusions in the Procurement Act 2023
How can smaller businesses finance their sustainability journey?
Read article How can smaller businesses finance their sustainability journey?
Sign up for our newsletter
Just add your details to receive updates and news from the British Business Bank
Sign up to our newsletter